Insider Transactions in Q2 2025 at Acadia Pharmaceuticals Inc (ACAD)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 08
2025
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,708
-4.36%
|
$37,912
$14.82 P/Share
|
|
Apr 08
2025
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,028
-4.41%
|
$14,392
$14.82 P/Share
|
|
Apr 05
2025
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,275
+7.82%
|
-
|
|
Apr 05
2025
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,010
+7.95%
|
-
|